Cargando…
Biomarker Development in Chronic Inflammatory Diseases
Chronic inflammatory diseases, such as inflammatory bowel disease—namely, Crohn’s disease and ulcerative colitis—psoriasis, multiple sclerosis, rheumatoid arthritis, and many others affect millions of people worldwide, causing a high burden of disease, socioeconomic impact, and healthcare cost. Thes...
Autores principales: | Katsanos, Aristeidis H., Kyriakidi, Kalliroi, Karassa, Fotini B., Politis, Dimitrios, Skamnelos, Alexandros, Christodoulou, Dimitrios K., Katsanos, Konstantinos H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122305/ http://dx.doi.org/10.1007/978-3-319-59856-7_3 |
Ejemplares similares
-
Serum Bile Acids Profiling in Inflammatory Bowel Disease Patients Treated with Anti-TNFs
por: Roda, Giulia, et al.
Publicado: (2019) -
Fast-track drug approval in inflammatory bowel diseases
por: Katsanos, Konstantinos H., et al.
Publicado: (2016) -
CD4 count remission hypothesis in patients with inflammatory bowel disease and human immunodeficiency virus infection: a systematic review of the literature
por: Skamnelos, Alexandros, et al.
Publicado: (2015) -
Pseudopolyps in inflammatory bowel diseases: Have we learned enough?
por: Politis, Dimitrios S, et al.
Publicado: (2017) -
Specific Features of Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
por: Fousekis, Fotios S., et al.
Publicado: (2019)